
Literary Reviews
Alliance Pharmaceuticals search through a number of professional journals to bring you a summary of the most up to date information.
Access previous editions
You need the free Adobe Reader to view and print the Literary reviews, this can be downloaded by using this Adobe Reader link.
The Literary review is provided free from Copyright infringements. It is created wholly inhouse by personal review of the technical journals. We have made every effort that they should be free from error. Please contact us if you have any concerns.
The Literary review is provided free from Copyright infringements. It is created wholly inhouse by personal review of the technical journals. We have made every effort that they should be free from error. Please contact us if you have any concerns.
2022
Access the latest editions from 2022
2021
Access the latest editions from 2021
2020
Access the latest editions from 2020
2019
Access the latest editions from 2019
NEXT SECTION
Eczema and Dry Skin
Eczema is an inflammatory skin condition that causes dry skin, itchiness, rashes, blistering, and skin infections. There are a number of different types of eczema.
Find out more about eczema and dry skin conditions.
Find out more about eczema and dry skin conditions.
NEXT SECTION
Diagnosis
There are a number of steps to diagnosing eczema, in line with NICE guidelines.
Find out more about how to diagnose eczema.
Find out more about how to diagnose eczema.
NEXT SECTION
Treatment Options
There are a number of different treatments available to patients from moisturisers to topical steroids.
Find out more about the different treatment options for eczema.
Find out more about the different treatment options for eczema.
NEXT SECTION
Burden Of Itch
Chronic itch, defined as an itch lasting for longer than 6 weeks, is a highly
prevalent symptom of dry skin conditions along with the skin becoming dry,
cracked and irritated.
NEXT SECTION
Clinical Presentation
The main clinical presentation of eczema and dry skin conditions is skin becoming scratchy, dry, cracked, and irritated.
Find out more about the clinical presentation of eczema.
Find out more about the clinical presentation of eczema.
NEXT SECTION
Woundcare
Healthy skin can become vulnerable due to a number of reasons.
Find out more about the role emollients play in caring for vulnerable skin.
Find out more about the role emollients play in caring for vulnerable skin.
NEXT SECTION
Follow-up and Referral
Recommendations for referral to secondary care, from the guidelines for management of atopic eczema from the Primary Care Dermatology Society and British Association of Dermatologists.
Find out more about when to follow-up and when to refer patients.
Find out more about when to follow-up and when to refer patients.
NEXT SECTION
Hydromol Range
The Hydromol range is used for the treatment of dry skin and eczema. Each emollient can be used individually, or together as a Complete Emollient Therapy regime.
Discover the Hydromol Range.
Discover the Hydromol Range.
NEXT SECTION
Complete Emollient Therapy
Complete Emollient Therapy, or CET, involves the frequent and liberal application of emollient moisturisers to the skin, and the replacement of wash products with emollient equivalents.
Find out more about Complete Emollient Therapy
Find out more about Complete Emollient Therapy
NEXT SECTION
Literature Reviews
Alliance Pharmaceuticals search through a number of professional journals to bring you a summary of the most up to date information.
Browse Dermatology literature reviews from 2019.
Browse Dermatology literature reviews from 2019.
NEXT SECTION
Eczema and Dry Skin
Eczema is an inflammatory skin condition that causes dry skin, itchiness, rashes, blistering, and skin infections. There are a number of different types of eczema.
Find out more about eczema and dry skin conditions.
Find out more about eczema and dry skin conditions.
NEXT SECTION
Diagnosis
There are a number of steps to diagnosing eczema, in line with NICE guidelines.
Find out more about how to diagnose eczema.
Find out more about how to diagnose eczema.
NEXT SECTION
Treatment Options
There are a number of different treatments available to patients from moisturisers to topical steroids.
Find out more about the different treatment options for eczema.
Find out more about the different treatment options for eczema.
NEXT SECTION
Burden Of Itch
Chronic itch, defined as an itch lasting for longer than 6 weeks, is a highly
prevalent symptom of dry skin conditions along with the skin becoming dry,
cracked and irritated.
NEXT SECTION
Clinical Presentation
The main clinical presentation of eczema and dry skin conditions is skin becoming scratchy, dry, cracked, and irritated.
Find out more about the clinical presentation of eczema.
Find out more about the clinical presentation of eczema.
NEXT SECTION
Woundcare
Healthy skin can become vulnerable due to a number of reasons.
Find out more about the role emollients play in caring for vulnerable skin.
Find out more about the role emollients play in caring for vulnerable skin.
NEXT SECTION
Follow-up and Referral
Recommendations for referral to secondary care, from the guidelines for management of atopic eczema from the Primary Care Dermatology Society and British Association of Dermatologists.
Find out more about when to follow-up and when to refer patients.
Find out more about when to follow-up and when to refer patients.
NEXT SECTION
Hydromol Range
The Hydromol range is used for the treatment of dry skin and eczema. Each emollient can be used individually, or together as a Complete Emollient Therapy regime.
Discover the Hydromol Range.
Discover the Hydromol Range.
NEXT SECTION
Complete Emollient Therapy
Complete Emollient Therapy, or CET, involves the frequent and liberal application of emollient moisturisers to the skin, and the replacement of wash products with emollient equivalents.
Find out more about Complete Emollient Therapy
Find out more about Complete Emollient Therapy
NEXT SECTION
Literature Reviews
Alliance Pharmaceuticals search through a number of professional journals to bring you a summary of the most up to date information.
Browse Dermatology literature reviews from 2019.
Browse Dermatology literature reviews from 2019.
1. Boguniewicz, M. Zeichner, JA. Eichenfield, LF. at al. Journal of Paediatrics. 2008; 152: 854-859.
2. Zirwas, M. J. & Barkovic, S. J. Drugs Dermatol. 2016; 16:243-247.
3. Abramovitis, W. Kemper, S. Tschen, E. at al. Journal of Drugs in Dermatology. 2006; 5(3): 236-244.
4. Pinter, A. et al. Dermatol Ther. 2019;9: 309-319.
5. Poljšak, N. & Kočevar Glavač, N. Front. Pharmacol. 2022; 13, 868461.
6. Atopiclair Cream ETF011. Alliance Pharmaceuticals.
7. Patrizi, A. Capitanio, B. Neri, I et al Paediatric Allergy and Immunology. 2009; 19: 619-625
8. Giam, YC. Herbert, AA. Dizon, MV et al. Asia Pacific Allergy. 2016; 6: 120-128.
9. BNF, Emollients. 10. Cork MJ. Optimising Treatment of Atopic Dermatitis: The Emollient to Topical Steroid Prescribing Ratio. Scientific Insights Report, 2003.
11. Cork MJ. Skin barrier breakdown: a renaissance in emollient therapy. BJN 2009;18(14):872-877
12. British Association of Dermatologists patient information leaflet. Atopic Eczema. February 2017.
13. NHSBSA PCA Data (Feb 22).
14. NICE Clinical Guideline CG57. Atopic eczema in children. December 2007.
15. Clinical Knowledge Summaries, Eczema – atopic. http://cks.nice.org.uk/eczema-atopic#!diagnosissub. Last accessedApril 2023.
16. Data on File HYD/04.19/01; Mass residue experiment, University of Edinburgh, School of Physics
2. Zirwas, M. J. & Barkovic, S. J. Drugs Dermatol. 2016; 16:243-247.
3. Abramovitis, W. Kemper, S. Tschen, E. at al. Journal of Drugs in Dermatology. 2006; 5(3): 236-244.
4. Pinter, A. et al. Dermatol Ther. 2019;9: 309-319.
5. Poljšak, N. & Kočevar Glavač, N. Front. Pharmacol. 2022; 13, 868461.
6. Atopiclair Cream ETF011. Alliance Pharmaceuticals.
7. Patrizi, A. Capitanio, B. Neri, I et al Paediatric Allergy and Immunology. 2009; 19: 619-625
8. Giam, YC. Herbert, AA. Dizon, MV et al. Asia Pacific Allergy. 2016; 6: 120-128.
9. BNF, Emollients. 10. Cork MJ. Optimising Treatment of Atopic Dermatitis: The Emollient to Topical Steroid Prescribing Ratio. Scientific Insights Report, 2003.
11. Cork MJ. Skin barrier breakdown: a renaissance in emollient therapy. BJN 2009;18(14):872-877
12. British Association of Dermatologists patient information leaflet. Atopic Eczema. February 2017.
13. NHSBSA PCA Data (Feb 22).
14. NICE Clinical Guideline CG57. Atopic eczema in children. December 2007.
15. Clinical Knowledge Summaries, Eczema – atopic. http://cks.nice.org.uk/eczema-atopic#!diagnosissub. Last accessedApril 2023.
16. Data on File HYD/04.19/01; Mass residue experiment, University of Edinburgh, School of Physics